Time & Location
May 12, 2022, 12:00 PM – 1:00 PM
About the Event
Join us as we moderate this wonderful opportunity to hear from Dr. Daniel Corcos on exactly what research-based exercise he perceives to be the right "prescription" for managing your Parkinson's symptoms.
Please email questions ahead of the event to firstname.lastname@example.org
Daniel Corcos obtained his PhD in 1982 in Motor Control from the University of Oregon. He did a Post-Doctoral Fellowship in the Department of Neurosurgery at Rush Medical Center from 1983-1987. Dr. Corcos was an Assistant Professor at the University of Illinois at Chicago from 1987-1993, was promoted to the rank of Associate Professor with tenure in 1993, and to Full Professor in 1997.
He is currently a tenured Full Professor at Northwestern University. He has published more than 200 peer reviewed research articles and his research has been cited more than 13,000 times. He has an H index of 66. He has been continuously funded by NIH since 1986. He has been the recipient of both a First Independent Research Support and Transition (FIRST) award and a Research Career Development Award (RCDA) as well as 9 R01 grants and 2 U01 grants. He has been awarded more than $40,000,000 in grant funding. He was selected for membership in the National Academy of Kinesiology in 2001 and was made an Honorary Member of the American Physical Therapy Association in 2018. He has served on NIH study sections since 1994 and was the Chair of the Musculoskeletal and Rehabilitation Sciences Study Section at NIH from 2003 to 2006 and was chair the Musculoskeletal Function and Speech Rehabilitation study section from 2011 to 2013. He was an Editor of the Journal of Motor Behavior from 1996 to 2014. He is currently on the Editorial Board of both the Journal of Neuroengineering and also the Journal of Neurorehabilitation and Neural Repair. He has completed a clinical trial on the effects of progressive resistance exercise in Parkinson’s disease that demonstrated clear benefits on the motor symptoms of the disease as well as benefits of exercise on cognition. His paper on cognition was voted paper of the year in the journal Movement Disorders in 2015. His paper on gait was voted paper of the year in the year in 2017 in the Journal of Neurological Physical Therapy.
He was the co-principal investigator on a Phase II clinical trial on the effects of different doses of endurance exercise on patients with Parkinson’s disease. The paper that resulted from this trial showed that high intensity endurance exercise slows down the rate at which Parkinson’s disease progresses. The paper was published in the Journal of the American Medical Association Neurology. The findings have been covered in the New York Times and the general press world-wide. He is currently the PI of a follow-up Phase III clinical trial on endurance exercise: SPARX3.